Browsing Category
Pharma Industry News
4750 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
GSK to acquire efimosfermin from Boston Pharmaceuticals for $2bn to bolster liver disease pipeline
GSK acquires Phase III-ready efimosfermin from Boston Pharmaceuticals for $2B, expanding its liver disease pipeline with a fibrosis-reversing specialty drug.
Eli Lilly strengthens ties with Purdue University to advance AI-powered drug discovery
Eli Lilly expands Purdue partnership with a $250M investment to drive AI-powered drug discovery, R&D scalability, and long-term pharma innovation.
Novo Nordisk and Septerna forge $2.2bn GPCR deal to develop oral therapies for obesity and diabetes
Novo Nordisk partners with Septerna in a $2.2B deal to develop oral GPCR therapies for obesity and diabetes. Explore the full stock sentiment and deal impact.
GSK India delivers 32% profit surge—Zejula and Jemperli launches set to transform cancer care
GSK India reports 32% PAT growth in FY25; read how oncology launches and vaccine growth are shaping the company’s future outlook.
Aurobindo Pharma’s next big break? CuraTeQ’s biosimilar Zefylti gets UK green light after EU win
CuraTeQ Biologics earns MHRA approval for biosimilar Zefylti, boosting Aurobindo Pharma’s biosimilar push in the UK and EU markets. Read more.
Stablepharma begins world’s first fridge-free vaccine trials; Is the cold chain era ending?
Stablepharma launches the first-ever fridge-free vaccine trial for tetanus and diphtheria—SPVX02—potentially reshaping global vaccine distribution forever.
Hoth Therapeutics advances HT-KIT: Preclinical success sets stage for human trials and stock market interest
Hoth Therapeutics reports tumor suppression with no toxicity for HT-KIT. Learn how this biotech play could reshape cancer care and investor sentiment.
Zepbound outperforms Wegovy in SURMOUNT-5 trial: Eli Lilly’s weight-loss drug achieves 47% greater relative reduction
Zepbound outperforms Wegovy with 20.2% weight loss in SURMOUNT-5 trial. See how Eli Lilly’s stock and investor sentiment responded to this clinical milestone.
CARsgen’s CT0596 CAR-T shows strong early results in refractory myeloma
CARsgen’s allogeneic CAR-T therapy CT0596 shows early safety and efficacy in myeloma—find out how investors are reacting to the 2025 breakthrough.
Solara Active Pharma’s Ambernath site clears third consecutive USFDA audit with Zero 483 observations
Solara’s Ambernath facility clears USFDA audit with zero 483s, boosting investor confidence despite financial caution. Read why institutions are watching closely.